Holen Sie sich die Stockscreener-App
11.49
4.33%
-0.52
Schlusskurs vom Vortag:
$12.01
Offen:
$11.77
24-Stunden-Volumen:
1.68M
Relative Volume:
1.35
Marktkapitalisierung:
$895.19M
Einnahmen:
$1.53B
Nettoeinkommen (Verlust:
$40.23M
KGV:
22.98
EPS:
0.5
Netto-Cashflow:
$60.93M
1W Leistung:
-27.87%
1M Leistung:
-22.36%
6M Leistung:
-31.81%
1J Leistung:
-40.40%
1-Tages-Spanne:
$11.08
$11.85
1-Wochen-Bereich:
$11.05
$15.85
52-Wochen-Spanne:
$11.05
$27.13
Integra Lifesciences Holdings Corp Stock (IART) Company Profile
Firmenname
Integra Lifesciences Holdings Corp
Sektor
Branche
Telefon
(609) 275-0500
Adresse
1100 CAMPUS ROAD, PRINCETON, NJ
Vergleichen Sie IART mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IART
Integra Lifesciences Holdings Corp
|
11.49 | 935.48M | 1.53B | 40.23M | 60.93M | 0.50 |
|
ABT
Abbott Laboratories
|
123.84 | 214.96B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.59 | 149.24B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
358.16 | 136.23B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
90.20 | 116.33B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
83.07 | 48.41B | 5.88B | 1.34B | 577.90M | 2.3455 |
Integra Lifesciences Holdings Corp Stock (IART) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-31 | Hochstufung | Argus | Hold → Buy |
| 2024-12-02 | Eingeleitet | Morgan Stanley | Underweight |
| 2024-10-07 | Hochstufung | BTIG Research | Sell → Neutral |
| 2024-07-30 | Herabstufung | BTIG Research | Neutral → Sell |
| 2024-07-30 | Herabstufung | Citigroup | Neutral → Sell |
| 2024-05-07 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2024-05-07 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-04-03 | Hochstufung | Citigroup | Sell → Neutral |
| 2023-12-05 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-11-14 | Eingeleitet | CL King | Buy |
| 2023-08-24 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2023-07-12 | Hochstufung | Jefferies | Hold → Buy |
| 2023-06-08 | Herabstufung | Argus | Buy → Hold |
| 2023-05-24 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2023-05-23 | Herabstufung | Citigroup | Neutral → Sell |
| 2022-10-12 | Eingeleitet | Jefferies | Hold |
| 2022-07-25 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2022-04-13 | Herabstufung | Truist | Buy → Hold |
| 2021-12-17 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2021-09-15 | Herabstufung | BTIG Research | Buy → Neutral |
| 2020-10-08 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2020-05-27 | Eingeleitet | Citigroup | Neutral |
| 2020-04-03 | Eingeleitet | SunTrust | Buy |
| 2020-01-07 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2020-01-07 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2019-01-03 | Eingeleitet | SunTrust | Buy |
| 2018-11-28 | Eingeleitet | UBS | Neutral |
| 2018-08-07 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2018-07-26 | Hochstufung | BTIG Research | Neutral → Buy |
| 2018-07-02 | Herabstufung | Citigroup | Buy → Neutral |
| 2018-01-05 | Fortgesetzt | Cantor Fitzgerald | Neutral |
| 2018-01-02 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2017-11-09 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2017-10-30 | Herabstufung | Wells Fargo | Outperform → Market Perform |
| 2017-10-27 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2017-06-30 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2017-05-02 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2017-01-13 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2017-01-06 | Hochstufung | JMP Securities | Mkt Perform → Mkt Outperform |
| 2016-12-12 | Eingeleitet | UBS | Buy |
Alle ansehen
Integra Lifesciences Holdings Corp Aktie (IART) Neueste Nachrichten
Why Integra LifeSciences (IART) Shares Are Trading Lower Today - Yahoo Finance
Integra Lifesciences (IART) Sees Revised Analyst Ratings Today | IART Stock News - GuruFocus
Is Integra LifeSciences Holdings Corporation (IL3) stock a top pick for value investors2025 Growth vs Value & Fast Exit and Entry Strategy Plans - newser.com
Integra LifeSciences Holdings Corporation stock trend forecastMarket Volume Summary & Long Hold Capital Preservation Tips - newser.com
How Integra LifeSciences Holdings Corporation (IL3) stock responds to bond marketQuarterly Profit Review & Capital Efficiency Focused Strategies - newser.com
Published on: 2025-11-03 05:22:14 - newser.com
Does Integra LifeSciences Holdings Corporation show high probability of rebound2025 Earnings Impact & Accurate Intraday Trading Signals - newser.com
Published on: 2025-11-02 20:58:58 - newser.com
Will Integra LifeSciences Holdings Corporation (IL3) stock profit from AI boomLong Setup & Free Growth Oriented Trading Recommendations - newser.com
Is Integra LifeSciences Holdings Corporation stock vulnerable to regulatory risksMarket Rally & Safe Entry Trade Reports - newser.com
Integra LifeSciences (IART): Deep Losses and Discounted Valuation Shape Sentiment Ahead of Earnings - Yahoo Finance
Integra LifeSciences (NASDAQ:IART) Price Target Cut to $11.00 by Analysts at Citigroup - MarketBeat
Integra LifeSciences Hits 52-Week Low at USD 11.05 Amidst Decline - Markets Mojo
Integra LifeSciences Holdings Corporation (NASDAQ:IART) Q3 2025 Earnings Call Transcript - Insider Monkey
Integra LifeSciences (NASDAQ:IART) Hits New 52-Week LowHere's What Happened - MarketBeat
How buyback programs support Integra LifeSciences Holdings Corporation (IL3) stockIndex Update & Safe Swing Trade Setup Alerts - newser.com
Is Integra LifeSciences Holdings Corporation stock poised for growthWeekly Market Outlook & Weekly Stock Performance Updates - newser.com
Technical signs of recovery in Integra LifeSciences Holdings CorporationJuly 2025 Breakouts & Reliable Price Breakout Alerts - newser.com
Intraday pattern recognizer results for Integra LifeSciences Holdings CorporationOptions Play & Reliable Entry Point Trade Alerts - newser.com
Integra LifeSciences (NASDAQ:IART) Issues Earnings Results - MarketBeat
Integra LifeSciences (NASDAQ:IART) Trading Down 23.2%What's Next? - MarketBeat
Citigroup Maintains "Sell" Rating on Integra Lifesciences (IART) with Lowered Price Target | IART Stock News - GuruFocus
Integra LifeSciences Hits Day Low of $11.05 Amid Price Pressure - Markets Mojo
JP Morgan Raises Price Target for Integra Lifesciences (IART) to $13 | IART Stock News - GuruFocus
Integra LifeSciences (NASDAQ:IART) Releases Q4 2025 Earnings Guidance - MarketBeat
Does Integra LifeSciences Holdings Corporation qualify in momentum factor screeningJuly 2025 Highlights & Fast Moving Market Watchlists - newser.com
How to use Fibonacci retracement on Integra LifeSciences Holdings CorporationQuarterly Risk Review & Daily Chart Pattern Signal Reports - newser.com
Integra: Q3 Earnings Snapshot - Stamford Advocate
Is Integra LifeSciences Holdings Corporation stock undervalued vs historical averagesWeekly Market Outlook & Entry Point Confirmation Signals - newser.com
Will Integra LifeSciences Holdings Corporation stock deliver better than expected guidance - newser.com
Integra LifeSciences Holdings Corporation (IART) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Integra Lifesciences Holdings Corp (IART) Q3 2025 Earnings Call Highlights: Strong EPS Growth ... By GuruFocus - Investing.com Canada
Integra Lifesciences Holdings Corp (IART) Q3 2025 Earnings Call Highlights: Strong EPS Growth ... - Yahoo Finance
Integra LifeSciences Q3 revenue $402,062 amid $511,365 impairment YTD - Stock Titan
Integra Lifesciences Holdings Corp (IART) Q3 2025 Earnings Call - GuruFocus
Integra LifeSciences Drops After Cutting Revenue Outlook - Finimize
Why Integra LifeSciences (IART) Shares Are Sliding Today - Yahoo Finance
Integra LifeSciences (IART) Reports Strong Q3 Despite Supply Cha - GuruFocus
Integra LifeSciences stock hits 52-week low at 11.05 USD - Investing.com
Will Integra LifeSciences Holdings Corporation (IL3) stock gain from lower interest ratesEarnings Recap Report & Consistent Return Strategy Ideas - newser.com
Earnings call transcript: Integra LifeSciences Q3 2025 beats EPS expectations - Investing.com
Integra LifeSciences Q3 Loss Narrows; Cuts FY25 Revenue Guidance; Stock Up - Nasdaq
Integra LifeSciences Holdings C (IART) Q3 FY2025 earnings call transcript - Yahoo Finance
Integra LifeSciences Q3 Adj. EPS Tops Estimates, But Revenues Miss - Nasdaq
Integra LifeSciences Slashes FY25 OutlookUpdate - Nasdaq
Integra LifeSciences (IART) Q3 Earnings Beat Estimates - Yahoo Finance
Integra LifeSciences beats on earnings despite revenue miss - Investing.com
Integra Lifesciences Q3 2025 Earnings: Adjusted EPS of $0.54 Sur - GuruFocus
Integra LifeSciences (IART) Reports Q3 Revenue Below Expectations - GuruFocus
Integra LifeSciences Reports Third Quarter 2025 Financial Results - TradingView
IART furnishes Q3 2025 results with GAAP-to-non-GAAP reconciliations - Stock Titan
Finanzdaten der Integra Lifesciences Holdings Corp-Aktie (IART)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.84%
0.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):